STI and Vaginitis PCR Testing Market

The STI and Vaginitis PCR Testing market consists of advanced diagnostic tests using polymerase chain reaction (PCR) technology for the specific detection of pathogens causing sexually transmitted and vaginal infections. Key customers include diagnostic laboratories, hospitals, clinics, and consumers using at-home tests. The market's growth is primarily driven by the rising prevalence of these infections, advancements in molecular diagnostics like multiplex PCR assays, and increased public awareness leading to more proactive screening.

CAGR

9%

Compound Annual Growth Rate

Current Value

$790.0M

Estimated 2026

Projected Value

$1.58B

By 2034